News/Announcements
Pinned content, custom sorted.
Leadership Position Open in the Human Subjects Office
Wednesday, March 18, 2026
The HSO is hiring a leadership position focused on Education and Compliance! Come join our team.
Pinned content, custom sorted.
Changes to Student PI Training Requirement Course
Monday, March 9, 2026
Graduate and undergraduate student principal investigators (PIs) are required to view recorded trainings about the HawkIRB New Project form prior to submitting an application in HawkIRB.
Pinned content, custom sorted.
Section VII Updates Now Live as Part of the HawkIRB Application Redesign
Sunday, February 15, 2026
Section VII changes as part of the HawkIRB application redesign project are now live.
Pinned content, custom sorted.
New IRB Connection Newsletter
Thursday, January 29, 2026
The latest edition of the IRB Connection Newsletter is now available.
Pinned content, custom sorted.
FY26 IRB Fee Updates effective November 1, 2025
Friday, August 29, 2025
Changes to IRB Fees effective November 1, 2025.
Section VII Office Hours
Wednesday, February 4, 2026
Special HawkIRB Section VII. Office Hours on February 11th and 18th from 12:00 - 1:00 PM
2026 IRS Reporting Threshold Changes Impacting Research Subject Compensation
Wednesday, January 28, 2026
IRS reporting changes will increase the threshold for IRS reporting requirements for human subjects research compensation.
Position Open in the Human Subjects Office-Come Join Our Team!
Wednesday, January 14, 2026
This Professional and Scientific position will be filled as either a Conflict of Interest in Research (COIR) Analyst (PRD1) or Senior COIR Analyst (PRD2) based on candidate qualifications of the successful candidate.
HSO Closed 12/24/25 @ 1:00pm and will resume operations on 12/29/25
Tuesday, December 9, 2025
The Human Subjects Office holiday closure will be 12/24/25-12/28/25 and 12/31/25 @ 1:00pm-1/1/26.
Update to CITI GCP Training
Wednesday, September 24, 2025
CITI GCP modules updated to align with the ICH E6(R3) guidelines and the recently released final guidance from the FDA for E6(R3) Good Clinical Practice.
Pagination